Who
David L. Barker
Director
Company insider
Files Form 4 as: Director, Bionano Genomics; Director, Singular Genomics Systems.
In numbers
- Trades disclosed
- 27
- Buys
- 2
- Sells
- 0
- Bought
- $41K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 21 Aug 2018
- Last trade
- 14 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 14 May 2026 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,149 at $0.00 | filing |
| 14 May 2026filed 14 May 2026 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,149 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,775 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —666 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —1,541 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | —2,466 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code D | $22K2,466 at $8.84 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systems | SEC FORM 4 Code D | —60,000 | filing |
| 21 Feb 2025filed 25 Feb 2025 | Singular Genomics Systems | SEC FORM 4 Code D | —1,000,000 | filing |
| 18 Jun 2024filed 20 Jun 2024 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code A | —74,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code A | —74,000 at $0.00 | filing |
| 7 Jul 2022filed 11 Jul 2022 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 7 Jul 2022filed 11 Jul 2022 | Singular Genomics Systems | SEC FORM 4 Code M | $38K60,000 at $0.63 | filing |
| 7 Jul 2022filed 11 Jul 2022 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code M | —44,470 at $0.00 | filing |
| 7 Jul 2022filed 11 Jul 2022 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Code M | $23K44,470 at $0.51 | filing |
| 9 Jun 2022filed 13 Jun 2022 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —164,422 at $0.00 | filing |
| 26 May 2022filed 31 May 2022 | Singular Genomics Systemsoption or derivative | SEC FORM 4 Code A | —46,250 at $0.00 | filing |
| 16 May 2022filed 18 May 2022 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Bought | $16K10,000 at $1.60 | filing |
News
Critical Analysis: Bionano Genomics (NASDAQ:BNGO) & Personalis (NASDAQ:PSNL)BNGO · tickerreport.com · 24 Oct 2026
0 headlines in the last 90 days name David L. Barker; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.